With 283.95 million shares changed hands, the volume of the stock remained heavier than its average volume of 6.14 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $3.67 whereas the lowest price it dropped to was $1.41. The 52-week range on ONMD shows that it touched its highest point at $1.56 and its lowest point at $0.30 during that stretch. Beta for the stock currently stands at 0.99.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ONMD was up-trending over the past week, with a rise of 141.51%, but this was up by 194.76% over a month. Three-month performance surged to 361.26% while six-month performance rose 428.27%. The stock gained 88.24% in the past year, while it has gained 341.15% so far this year.
Float and Shares Shorts:
At present, 46.10 million ONMD shares are outstanding with a float of 30.44 million shares on hand for trading. On 2025-09-15, short shares totaled 0.84 million, which was 183.0 higher than short shares on 1755216000. In addition to Dr. Jeffrey Yu M.D. as the firm’s Founder, VP, Chief Medical Officer & Chairman, Mr. Aaron Green serves as its CEO, President & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, ONMD reported revenue of $155000.0 and operating income of -$2063000.0. The EBITDA in the recently reported quarter was -$919000.0 and diluted EPS was $0.07.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
